Claire Conway
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Claire Conway has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Elazer Reuven Edelman
Harvard Medical School
4 shared publications - Aamir Hameed
Tissue Engineering Research Group (TERG), Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, 123 St. Stephen's Green, Dublin D02 YN77, Ireland; Trinity Centre for Biomedical Engineering (TCBE), Trinity College Dublin (TCD), Dublin, Ireland
3 shared publications David G. Symes
Biomedical Engineering, School of Engineering, College of Science and Engineering, University of Galway, Galway, Ireland
2 shared publicationsJ. P. McGarry
Biomechanics Research Centre (BMEC), Biomedical Engineering, College of Engineering and Informatics, National University of Ireland Galway, Galway, Ireland
2 shared publicationsLaoise M. McNamara
Biomedical Engineering, School of Engineering, College of Science and Engineering, University of Galway, Galway, Ireland
2 shared publicationsP. E. McHugh
Biomechanics Research Centre (BMEC), Biomedical Engineering, College of Engineering and Informatics, National University of Ireland Galway, Galway, Ireland
2 shared publications
Latest Publications
- Open Access
Left atrial strain assessment in mitral regurgitation: a systematic review
Objectives: Mitral regurgitation (MR) induces progressive atrial remodelling and dysfunction, yet conventional metrics may underestimate early mechanical impairment. This systematic review synthesised evidence on left atrial strain (LAS) across MR phenotypes, its prognostic utility and its response to intervention. Design: Systematic review conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data sources: MEDLINE, PubMed, Embase, CENTRAL and Web of Science were searched from 1 January 2010 to 10 July 2026. Eligibility criteria: Studies of adult patients with MR of any aetiology or severity using speckle-tracking echocardiography to report quantitative LAS. Case reports, reviews, conference abstracts without full text and non-English publications were excluded. Data extraction and synthesis: Two reviewers independently extracted data and assessed the risk of bias using the Risk of Bias in Non-Randomised Studies of Exposures tool, with a third reviewer resolving disagreements. Substantial heterogeneity precluded quantitative meta-analysis. Results: Left atrial reservoir strain (LASr) was universally reduced in patients with MR compared with controls across all aetiologies. Secondary MR demonstrated more severe impairment than primary MR, reflecting combined volume and pressure overload. Progressive LAS deterioration accompanied increasing MR severity, with LASr independently predicting surgical necessity and outperforming left ventricular global longitudinal strain as a severity marker. Multiple prognostic thresholds demonstrated independent predictive value for adverse outcomes: LASr <35% predicted cardiovascular events, while LASr ≤15% in secondary MR independently predicted mortality. Postintervention LAS responses demonstrated substantial heterogeneity; patients achieving ≥15% LASr improvement experienced significantly lower all-cause mortality and heart failure hospitalisation, establishing LAS recovery as a surrogate marker of successful reverse remodelling. Conclusions: LASr is a sensitive, consistent marker of atrial dysfunction in MR, identifying mechanical impairment prior to irreversible remodelling. As most supporting evidence is retrospective and single-centre, further prospective validation will help establish standardised thresholds for clinical use. PROSPERO registration number: CRD420251126721.
Open AccessLeft atrial strain assessment in mitral regurgitation: a systematic review
Objectives: Mitral regurgitation (MR) induces progressive atrial remodelling and dysfunction, yet conventional metrics may underestimate early mechanical impairment. This systematic review synthesised evidence on left atrial strain (LAS) across MR phenotypes, its prognostic utility and its response to intervention. Design: Systematic review conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data sources: MEDLINE, PubMed, Embase, CENTRAL and Web of Science were searched from 1 January 2010 to 10 July 2026. Eligibility criteria: Studies of adult patients with MR of any aetiology or severity using speckle-tracking echocardiography to report quantitative LAS. Case reports, reviews, conference abstracts without full text and non-English publications were excluded. Data extraction and synthesis: Two reviewers independently extracted data and assessed the risk of bias using the Risk of Bias in Non-Randomised Studies of Exposures tool, with a third reviewer resolving disagreements. Substantial heterogeneity precluded quantitative meta-analysis. Results: Left atrial reservoir strain (LASr) was universally reduced in patients with MR compared with controls across all aetiologies. Secondary MR demonstrated more severe impairment than primary MR, reflecting combined volume and pressure overload. Progressive LAS deterioration accompanied increasing MR severity, with LASr independently predicting surgical necessity and outperforming left ventricular global longitudinal strain as a severity marker. Multiple prognostic thresholds demonstrated independent predictive value for adverse outcomes: LASr <35% predicted cardiovascular events, while LASr ≤15% in secondary MR independently predicted mortality. Postintervention LAS responses demonstrated substantial heterogeneity; patients achieving ≥15% LASr improvement experienced significantly lower all-cause mortality and heart failure hospitalisation, establishing LAS recovery as a surrogate marker of successful reverse remodelling. Conclusions: LASr is a sensitive, consistent marker of atrial dysfunction in MR, identifying mechanical impairment prior to irreversible remodelling. As most supporting evidence is retrospective and single-centre, further prospective validation will help establish standardised thresholds for clinical use. PROSPERO registration number: CRD420251126721.
- Open Access
- 15 May 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 217, 443-457
Development of a mechano-mimetic mitral valve – hybrid experimental and finite element analysis findings
- 15 May 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 217, 443-457
Open AccessDevelopment of a mechano-mimetic mitral valve – hybrid experimental and finite element analysis findings
- Open Access
- 9 April 2026
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 13 (1) , e79381
Evaluation of Wellby, a Cocreated Mobile App and Wearable to Support Stress Management and Overall Well-Being: Mixed Methods Acceptability and Usability Study
Background: Digital well-being support tools can offer adolescents tailored interventions embedded in their digital environments. However, there is a lack of high-quality, evidence-based digital interventions specifically designed for young people’s well-being needs. Wellby is a mobile app and wearable device cocreated with Irish secondary school students to support stress management and overall well-being. Objective: This study aimed to evaluate the acceptability and usability of the Wellby system using the technology acceptance model, focusing on ease of use, perceived usefulness, and behavioral intention among Irish secondary school students. Methods: A mixed methods acceptability and usability study was conducted with Irish secondary school students (n=43) across 3 schools: 2 mainstream secondary schools and 1 Youthreach center for early school leavers. Students accessed the Wellby mobile app for 8 weeks and received the custom wearable device for the final 4 weeks (April-May 2024). Wellby included mood tracking, to-do lists, educational resources, text-based health coaching, and heart rate variability biofeedback with guided breathing exercises. Acceptability and usability were evaluated using the user version of the Mobile App Rating Scale (uMARS), structured focus groups, and app engagement analytics. Secondary measures included baseline well-being questionnaires (Perceived Stress Scale, Pittsburgh Sleep Quality Index, and EPOCH Measure of Adolescent Well-Being). Results: Among survey respondents (n=29), uMARS subscale scores were high: information quality (mean 4.2/5.0), functionality (4.1/5.0), and aesthetics (4.1/5.0). The perceived impact subscale showed the highest scores for well-being awareness (3.8/5.0) and help-seeking intention (3.9/5.0). Of survey respondents who participated in prior co-design sessions, 88% (21/24) and 83% (20/24) felt the wearable and app, respectively, aligned with their co-design feedback. App engagement more than doubled following the introduction of the wearable and revealed that the wearable tab was most accessed (643/1688, 38% of interactions), followed by the home (430/1688, 25%), resources (338/1688, 20%), and coaching (277/1688, 16%) tabs. Focus group feedback highlighted the mood tracker as the most valued feature and identified technical improvements, including better battery life, enhanced Bluetooth connectivity, and more personalization options. Conclusions: This study demonstrates that cocreated digital well-being tools can achieve high acceptability and usability with Irish secondary school students. Applying the technology acceptance model effectively captured student experience through mixed methods feedback. Students particularly valued self-tracking and personalization features over coaching or educational features. These findings highlight the importance of aligning digital technologies with adolescents’ needs and preferences, such as features that encourage increased autonomy and identity formation. Future iterations of Wellby should address the technical limitations while continuing the involvement of students to adapt to their developmental needs and maintain high acceptability.
- 9 April 2026
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 13 (1) , e79381
Open AccessEvaluation of Wellby, a Cocreated Mobile App and Wearable to Support Stress Management and Overall Well-Being: Mixed Methods Acceptability and Usability Study
Background: Digital well-being support tools can offer adolescents tailored interventions embedded in their digital environments. However, there is a lack of high-quality, evidence-based digital interventions specifically designed for young people’s well-being needs. Wellby is a mobile app and wearable device cocreated with Irish secondary school students to support stress management and overall well-being. Objective: This study aimed to evaluate the acceptability and usability of the Wellby system using the technology acceptance model, focusing on ease of use, perceived usefulness, and behavioral intention among Irish secondary school students. Methods: A mixed methods acceptability and usability study was conducted with Irish secondary school students (n=43) across 3 schools: 2 mainstream secondary schools and 1 Youthreach center for early school leavers. Students accessed the Wellby mobile app for 8 weeks and received the custom wearable device for the final 4 weeks (April-May 2024). Wellby included mood tracking, to-do lists, educational resources, text-based health coaching, and heart rate variability biofeedback with guided breathing exercises. Acceptability and usability were evaluated using the user version of the Mobile App Rating Scale (uMARS), structured focus groups, and app engagement analytics. Secondary measures included baseline well-being questionnaires (Perceived Stress Scale, Pittsburgh Sleep Quality Index, and EPOCH Measure of Adolescent Well-Being). Results: Among survey respondents (n=29), uMARS subscale scores were high: information quality (mean 4.2/5.0), functionality (4.1/5.0), and aesthetics (4.1/5.0). The perceived impact subscale showed the highest scores for well-being awareness (3.8/5.0) and help-seeking intention (3.9/5.0). Of survey respondents who participated in prior co-design sessions, 88% (21/24) and 83% (20/24) felt the wearable and app, respectively, aligned with their co-design feedback. App engagement more than doubled following the introduction of the wearable and revealed that the wearable tab was most accessed (643/1688, 38% of interactions), followed by the home (430/1688, 25%), resources (338/1688, 20%), and coaching (277/1688, 16%) tabs. Focus group feedback highlighted the mood tracker as the most valued feature and identified technical improvements, including better battery life, enhanced Bluetooth connectivity, and more personalization options. Conclusions: This study demonstrates that cocreated digital well-being tools can achieve high acceptability and usability with Irish secondary school students. Applying the technology acceptance model effectively captured student experience through mixed methods feedback. Students particularly valued self-tracking and personalization features over coaching or educational features. These findings highlight the importance of aligning digital technologies with adolescents’ needs and preferences, such as features that encourage increased autonomy and identity formation. Future iterations of Wellby should address the technical limitations while continuing the involvement of students to adapt to their developmental needs and maintain high acceptability.
- Open Access
- 14 June 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 194, 110558
Patient-specific investigation into plaque rupture risk due to catheter tracking during TAVR
- 14 June 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 194, 110558
Open AccessPatient-specific investigation into plaque rupture risk due to catheter tracking during TAVR
- Open Access
- 8 April 2024
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 52 (6) , 1554-1567
Computational Investigation of Vessel Injury Due to Catheter Tracking During Transcatheter Aortic Valve Replacement
Catheter reaction forces during transcatheter valve replacement (TAVR) may result in injury to the vessel or plaque rupture, triggering distal embolization or thrombosis. In vitro test methods represent the arterial wall using synthetic proxies to determine catheter reaction forces during tracking, but whether they can account for reaction forces within the compliant aortic wall tissue in vivo is unknown. Moreover, the role of plaque inclusions is not well understood. Computational approaches have predicted the impact of TAVR positioning, migration, and leaflet distortion, but have not yet been applied to investigate aortic wall reaction forces and stresses during catheter tracking. In this study, we investigate the role that catheter design and aorta and plaque mechanical properties have on the risk of plaque rupture during TAVR catheter delivery. We report that, for trackability testing, a rigid test model provides a reasonable estimation of the peak reaction forces experienced during catheter tracking within compliant vessels. We investigated the risk of rupture of both the aortic tissue and calcified plaques. We report that there was no risk of diseased aortic tissue rupture based on an accepted aortic tissue stress threshold (4.2 MPa). However, we report that both the aortic and plaque tissue exceed a rupture stress threshold (300 kPa) with and without the presence of stiff and soft plaque inclusions. We also highlight the potential risks associated with shorter catheter tips during catheter tracking and demonstrate that increasing the contact surface will reduce peak contact pressures experienced in the tissue.
- 8 April 2024
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 52 (6) , 1554-1567
Open AccessComputational Investigation of Vessel Injury Due to Catheter Tracking During Transcatheter Aortic Valve Replacement
Catheter reaction forces during transcatheter valve replacement (TAVR) may result in injury to the vessel or plaque rupture, triggering distal embolization or thrombosis. In vitro test methods represent the arterial wall using synthetic proxies to determine catheter reaction forces during tracking, but whether they can account for reaction forces within the compliant aortic wall tissue in vivo is unknown. Moreover, the role of plaque inclusions is not well understood. Computational approaches have predicted the impact of TAVR positioning, migration, and leaflet distortion, but have not yet been applied to investigate aortic wall reaction forces and stresses during catheter tracking. In this study, we investigate the role that catheter design and aorta and plaque mechanical properties have on the risk of plaque rupture during TAVR catheter delivery. We report that, for trackability testing, a rigid test model provides a reasonable estimation of the peak reaction forces experienced during catheter tracking within compliant vessels. We investigated the risk of rupture of both the aortic tissue and calcified plaques. We report that there was no risk of diseased aortic tissue rupture based on an accepted aortic tissue stress threshold (4.2 MPa). However, we report that both the aortic and plaque tissue exceed a rupture stress threshold (300 kPa) with and without the presence of stiff and soft plaque inclusions. We also highlight the potential risks associated with shorter catheter tips during catheter tracking and demonstrate that increasing the contact surface will reduce peak contact pressures experienced in the tissue.
- Open Access
- 24 September 2022
- Published by Wiley in Journal of Anatomy
- Vol. 242 (1) , 50-63
A European update on transcatheter aortic valve implantation (TAVI) in the COVID era
Minimally invasive approaches for aortic valve replacement are now at the forefront of pathological aortic valve treatment. New trials show comparability of these devices to existing therapies, not only in high‐risk surgical cohorts but also in low‐risk and intermediate‐risk cohorts. This review provides vital clinical and anatomical background to aortic valvular disease treatment guidelines, while also providing an update on transcatheter aortic valve implantation (TAVI) devices in Europe, their interventional trials and associated complications.
- 24 September 2022
- Published by Wiley in Journal of Anatomy
- Vol. 242 (1) , 50-63
Open AccessA European update on transcatheter aortic valve implantation (TAVI) in the COVID era
Minimally invasive approaches for aortic valve replacement are now at the forefront of pathological aortic valve treatment. New trials show comparability of these devices to existing therapies, not only in high‐risk surgical cohorts but also in low‐risk and intermediate‐risk cohorts. This review provides vital clinical and anatomical background to aortic valvular disease treatment guidelines, while also providing an update on transcatheter aortic valve implantation (TAVI) devices in Europe, their interventional trials and associated complications.
- Open Access
- 20 April 2022
- Published by Wiley in Journal of Anatomy
- Vol. 242 (1) , 29-49
Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are very useful in improving outcomes in patients with advanced‐stage heart failure. Despite recent advances in LVAD development, pump thrombosis is one of the most severe adverse events caused by LVADs. The contact of blood with artificial materials of LVAD pumps and cannulas triggers the coagulation cascade. Heat spots, for example, produced by mechanical bearings are often subjected to thrombus build‐up when low‐flow situations impair washout and thus the necessary cooling does not happen. The formation of thrombus in an LVAD may compromise its function, causing a drop in flow and pumping power leading to failure of the LVAD, if left unattended. If a clot becomes dislodged and circulates in the bloodstream, it may disturb the flow or occlude the blood vessels in vital organs and cause internal damage that could be fatal, for example, ischemic stroke. That is why patients with LVADs are on anti‐coagulant medication. However, the anti‐coagulants can cause a set of issues for the patient—an example of gastrointestinal (GI) bleeding is given in illustration. On account of this, these devices are only used as a last resort in clinical practice. It is, therefore, necessary to develop devices with better mechanics of blood flow, performance and hemocompatibility. This paper discusses the development of LVADs through landmark clinical trials in detail and describes the evolution of device design to reduce the risk of pump thrombosis and achieve better hemocompatibility. Whilst driveline infection, right heart failure and arrhythmias have been recognised as LVAD‐related complications, this paper focuses on complications related to pump thrombosis, especially blood coagulopathy in detail and potential strategies to mitigate this complication. Furthermore, it also discusses the LVAD implantation techniques and their anatomical challenges.
- 20 April 2022
- Published by Wiley in Journal of Anatomy
- Vol. 242 (1) , 29-49
Open AccessAdvancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are very useful in improving outcomes in patients with advanced‐stage heart failure. Despite recent advances in LVAD development, pump thrombosis is one of the most severe adverse events caused by LVADs. The contact of blood with artificial materials of LVAD pumps and cannulas triggers the coagulation cascade. Heat spots, for example, produced by mechanical bearings are often subjected to thrombus build‐up when low‐flow situations impair washout and thus the necessary cooling does not happen. The formation of thrombus in an LVAD may compromise its function, causing a drop in flow and pumping power leading to failure of the LVAD, if left unattended. If a clot becomes dislodged and circulates in the bloodstream, it may disturb the flow or occlude the blood vessels in vital organs and cause internal damage that could be fatal, for example, ischemic stroke. That is why patients with LVADs are on anti‐coagulant medication. However, the anti‐coagulants can cause a set of issues for the patient—an example of gastrointestinal (GI) bleeding is given in illustration. On account of this, these devices are only used as a last resort in clinical practice. It is, therefore, necessary to develop devices with better mechanics of blood flow, performance and hemocompatibility. This paper discusses the development of LVADs through landmark clinical trials in detail and describes the evolution of device design to reduce the risk of pump thrombosis and achieve better hemocompatibility. Whilst driveline infection, right heart failure and arrhythmias have been recognised as LVAD‐related complications, this paper focuses on complications related to pump thrombosis, especially blood coagulopathy in detail and potential strategies to mitigate this complication. Furthermore, it also discusses the LVAD implantation techniques and their anatomical challenges.
- Open Access
- 24 January 2022
- Published by Taylor & Francis in Journal of Medical Engineering & Technology
- Vol. 46 (3) , 220-230
In silico modelling of aortic valve implants – predicting in vitro performance using finite element analysis
The competing structural and hemodynamic considerations in valve design generally require a large amount of in vitro hydrodynamic and durability testing during development, often resulting in inefficient “trial-and-error” prototyping. While in silico modelling through finite element analysis (FEA) has been widely used to inform valve design by optimising structural performance, few studies have exploited the potential insight FEA could provide into critical hemodynamic performance characteristics of the valve. The objective of this study is to demonstrate the potential of FEA to predict the hydrodynamic performance of tri-leaflet aortic valve implants obtained during development through in vitro testing. Several variations of tri-leaflet aortic valves were designed and manufactured using a synthetic polymer and hydrodynamic testing carried out using a pulsatile flow rig according to ISO 5840, with bulk hydrodynamic parameters measured. In silico models were developed in tandem and suitable surrogate measures were investigated as predictors of the hydrodynamic parameters. Through regression analysis, the in silico parameters of leaflet coaptation area, geometric orifice area and opening pressure were found to be suitable indicators of experimental in vitro hydrodynamic parameters: regurgitant fraction, effective orifice area and transvalvular pressure drop performance, respectively.
- 24 January 2022
- Published by Taylor & Francis in Journal of Medical Engineering & Technology
- Vol. 46 (3) , 220-230
Open AccessIn silico modelling of aortic valve implants – predicting in vitro performance using finite element analysis
The competing structural and hemodynamic considerations in valve design generally require a large amount of in vitro hydrodynamic and durability testing during development, often resulting in inefficient “trial-and-error” prototyping. While in silico modelling through finite element analysis (FEA) has been widely used to inform valve design by optimising structural performance, few studies have exploited the potential insight FEA could provide into critical hemodynamic performance characteristics of the valve. The objective of this study is to demonstrate the potential of FEA to predict the hydrodynamic performance of tri-leaflet aortic valve implants obtained during development through in vitro testing. Several variations of tri-leaflet aortic valves were designed and manufactured using a synthetic polymer and hydrodynamic testing carried out using a pulsatile flow rig according to ISO 5840, with bulk hydrodynamic parameters measured. In silico models were developed in tandem and suitable surrogate measures were investigated as predictors of the hydrodynamic parameters. Through regression analysis, the in silico parameters of leaflet coaptation area, geometric orifice area and opening pressure were found to be suitable indicators of experimental in vitro hydrodynamic parameters: regurgitant fraction, effective orifice area and transvalvular pressure drop performance, respectively.
- Open Access
- 15 October 2021
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Acute Stent-Induced Endothelial Denudation: Biomechanical Predictors of Vascular Injury
Recent concern for local drug delivery and withdrawal of the first Food and Drug Administration-approved bioresorbable scaffold emphasizes the need to optimize the relationships between stent design and drug release with imposed arterial injury and observed pharmacodynamics. In this study, we examine the hypothesis that vascular injury is predictable from stent design and that the expanding force of stent deployment results in increased circumferential stress in the arterial tissue, which may explain acute injury poststent deployment. Using both numerical simulations and ex vivo experiments on three different stent designs (slotted tube, corrugated ring, and delta wing), arterial injury due to device deployment was examined. Furthermore, using numerical simulations, the consequence of changing stent strut radial thickness on arterial wall shear stress and arterial circumferential stress distributions was examined. Regions with predicted arterial circumferential stress exceeding a threshold of 49.5 kPa compared favorably with observed ex vivo endothelial denudation for the three considered stent designs. In addition, increasing strut thickness was predicted to result in more areas of denudation and larger areas exposed to low wall shear stress. We conclude that the acute arterial injury, observed immediately following stent expansion, is caused by high circumferential hoop stresses in the interstrut region, and denuded area profiles are dependent on unit cell geometric features. Such findings when coupled with where drugs move might explain the drug–device interactions.
- 15 October 2021
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Open AccessAcute Stent-Induced Endothelial Denudation: Biomechanical Predictors of Vascular Injury
Recent concern for local drug delivery and withdrawal of the first Food and Drug Administration-approved bioresorbable scaffold emphasizes the need to optimize the relationships between stent design and drug release with imposed arterial injury and observed pharmacodynamics. In this study, we examine the hypothesis that vascular injury is predictable from stent design and that the expanding force of stent deployment results in increased circumferential stress in the arterial tissue, which may explain acute injury poststent deployment. Using both numerical simulations and ex vivo experiments on three different stent designs (slotted tube, corrugated ring, and delta wing), arterial injury due to device deployment was examined. Furthermore, using numerical simulations, the consequence of changing stent strut radial thickness on arterial wall shear stress and arterial circumferential stress distributions was examined. Regions with predicted arterial circumferential stress exceeding a threshold of 49.5 kPa compared favorably with observed ex vivo endothelial denudation for the three considered stent designs. In addition, increasing strut thickness was predicted to result in more areas of denudation and larger areas exposed to low wall shear stress. We conclude that the acute arterial injury, observed immediately following stent expansion, is caused by high circumferential hoop stresses in the interstrut region, and denuded area profiles are dependent on unit cell geometric features. Such findings when coupled with where drugs move might explain the drug–device interactions.
- Open Access
- 3 March 2021
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 77 (2) , 97-104
Diuretic therapy in congestive heart failure
In heart failure, fluid overload is a major pathological mechanism leading to vascular congestion, pulmonary congestion and elevated jugular venous pressures. Diuretics play a significant role in the management of patients with congestive heart failure. It is used to relieve the congestive symptoms of heart failure. However, the appropriate use of diuretics remains challenging due to various complications like electrolyte abnormalities, worsening renal function and diuretic resistance. This has prompted towards the search of safer and effective alternatives. This review evaluates the use of diuretics in congestive heart failure and discusses the complications of different types of diuretics, which is essential for successful management of congestion in patients with heart failure and hence to optimise the outcome for the patients.
- 3 March 2021
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 77 (2) , 97-104
Open AccessDiuretic therapy in congestive heart failure
In heart failure, fluid overload is a major pathological mechanism leading to vascular congestion, pulmonary congestion and elevated jugular venous pressures. Diuretics play a significant role in the management of patients with congestive heart failure. It is used to relieve the congestive symptoms of heart failure. However, the appropriate use of diuretics remains challenging due to various complications like electrolyte abnormalities, worsening renal function and diuretic resistance. This has prompted towards the search of safer and effective alternatives. This review evaluates the use of diuretics in congestive heart failure and discusses the complications of different types of diuretics, which is essential for successful management of congestion in patients with heart failure and hence to optimise the outcome for the patients.